NEW YORK--(BUSINESS WIRE)--Nov. 30, 2005--(Investrend Research Syndicate) A new research note on Callisto Pharmaceuticals Inc (AMEX: KAL) has been issued by Beacon Equity Research Senior Analyst, Shailesh Dhuri. The full report is available at http://www.beaconequityresearch.com and http://www.investrendresearch.com.
